Sylwia Baluta
Wrocław University of Science and Technology, Poland
Title: Healthcare Monitoring – Biosensors as Point-of-Care Testing Devices
Biography
Biography: Sylwia Baluta
Abstract
Chronic illnesses require continuous monitoring and medical intervention for efficient treatment to be achieved. Therefore, designing a responsive system that will reciprocate to the physicochemical changes may offer superior therapeutic activity [1]. In this respect, biosensors development, which offers constant, fast, selective and sensitive in situ monitoring is extremely important. Biosensors, thank to fast measurement, offer a powerful opportunity in early diagnosis and treatment of illness, which is an essential value in case of point-of-care (POC) testing. POC is mostly focused on patient with chronic illness, such as Alzheimer or Parkinson diseases, where the continuous monitoring of important analytes, is required to allow changing of the dosage and treatment period. The main role of neurotransmitters, such as dopamine (DA), serotonin (5-HT), norepinephrine (NE) or epinephrine (EP), is to excite, inhibit otherwise influence the activity of cells. Any irregularity in the level of neurotransmitters can lead to various serious mental or physical diseases, like Parkinson’s [3], Alzheimer’s [4,5], schizophrenia [6], depression [7], cardiovascular ailments [8] etc. Currently, there is any fully automated device, such as biosensor, available on the market which will allow to measure the level of neurotransmitters.